BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14568927)

  • 1. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].
    Stanic AK; Shashidharamurthy R; Bezbradica JS; Matsuki N; Yoshimura Y; Miyake S; Choi EY; Schell TD; Van Kaer L; Tevethia SS; Roopenian DC; Yamamura T; Joyce S
    J Immunol; 2003 Nov; 171(9):4539-51. PubMed ID: 14568927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs.
    Cantu C; Benlagha K; Savage PB; Bendelac A; Teyton L
    J Immunol; 2003 May; 170(9):4673-82. PubMed ID: 12707346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B.
    Stanic AK; Bezbradica JS; Park JJ; Van Kaer L; Boothby MR; Joyce S
    J Immunol; 2004 Apr; 172(8):4667-71. PubMed ID: 15067039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo.
    Bezbradica JS; Stanic AK; Matsuki N; Bour-Jordan H; Bluestone JA; Thomas JW; Unutmaz D; Van Kaer L; Joyce S
    J Immunol; 2005 Apr; 174(8):4696-705. PubMed ID: 15814694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
    Brossay L; Naidenko O; Burdin N; Matsuda J; Sakai T; Kronenberg M
    J Immunol; 1998 Nov; 161(10):5124-8. PubMed ID: 9820479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
    Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
    J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
    Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
    J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
    Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
    Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
    Schümann J; Voyle RB; Wei BY; MacDonald HR
    J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
    Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
    J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics.
    Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR
    Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.
    Sprengers D; Sillé FC; Derkow K; Besra GS; Janssen HL; Schott E; Boes M
    Gastroenterology; 2008 Jun; 134(7):2132-43. PubMed ID: 18549881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo response of invariant natural killer T cells to glycolipid antigens.
    Parekh VV; Lalani S; Van Kaer L
    Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
    J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.